MARTIN ANDREANSKY to Graft vs Host Disease
This is a "connection" page, showing publications MARTIN ANDREANSKY has written about Graft vs Host Disease.
Connection Strength
0.687
-
Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease. Pediatr Blood Cancer. 2015 Dec; 62(12):2226-8.
Score: 0.328
-
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplant Cell Ther. 2025 Oct; 31(10):826.e1-826.e10.
Score: 0.163
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
Score: 0.149
-
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial. Biol Blood Marrow Transplant. 2018 06; 24(6):1216-1222.
Score: 0.024
-
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
Score: 0.022